LDX — Lumos Diagnostics Holdings Share News
0.000.00%
- AU$84.05m
- AU$70.34m
- $13.19m
Brief: Lumos Diagnostics Holdings Signs Second ANZ Distribution Agreement For Febridx
Brief: Lumos Diagnostics Secures Follow-On Contract With Aptatek For PKU Device
Brief: Lumos Diagnostics Says Barda To Support Febridx Paediatric Study With $6.198 Mln Funding Package
Brief: Lumos Diagnostics Partners With Pro-Spectus For Febridx
Brief: Lumos Diagnostics Signs Binding Term Sheet For A$5.0 Million Loan Facility
Brief: Lumos Diagnostics Signs Exclusive U.S. Distribution Agreement With Phase Scientific For Febridx
Australia's Lumos Diagnostics soars most in two years on US distribution agreement
Brief: Lumos Diagnostics Holdings Ltd Says Trading In Securities Will Be Halted Until 15 July Pending Release Of Announcemen
Australia's Lumos Diagnostics gains on advancing respiratory test sales
Australia's Lumos Diagnostics hits two-month high on upbeat Q3 results
Brief: Lumos Diagnostics Reports Revenue Of Us$3.5 Million For Quarter
Brief: Lumos Diagnostics Posts HY Loss Attributable $2.8 Mln
Brief: Lumos Diagnostics Logs Unaudited Revenue $2.9 Mln For Qtr
Brief: Lumos Diagnostics Partners With MedPro For Sales Of FebriDX In US
Brief: Lumos Diagnostics Posts Unaudited Revenue Of $3.4 Mln For Qtr
Brief: Lumos Diagnostics And Barda To Partner To Support FebriDx Bacterial/Non-Bacterial Point-Of-Care Test
Australia's Lumos Diagnostics hits near 4-week high as co gets fresh funds
Brief: Lumos Diagnostics Holdings Awarded National Contract With Medigroup
Australia's Lumos Diagnostics set for best day in 8-1/2 months on US contract win